chief medical officer summit 2023

Ritz-Carlton, Pavilions 4 & 5 Eileen OReilly, MD Cerevance to Participate in Chief Medical Officer Summit Save The Date! As health care shifts towards home-based care, at-home diagnostic testing becomes a crucial link in the care path. SVP, Clinical Sciences, Head, Translational Science and Oncology, Regeneron Pharmaceuticals. News Meet the 2023-24 chief residents July 6, 2023 Matt Mallum, MFA As another academic year begins, four new chief residents have taken on leadership roles in the internal medicine residency program. Teri Foy, PhD How Radiomics is Being Used to Generate Value, 1:50 pm 2:05 pm LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads) on and off LinkedIn. Creating Real Change in Total Cost-of-Care Requires Real Change in Specialty Care, Primary care providers and specialists are struggling with data visibility issues that subsequently hinder better care management, higher quality, and cost containment. Senior Director, PET Imaging, Pfizer, Andy Lee CHIEF You can update your choices at any time in your settings. IO Cell therapy regulatory updates to include data of volume, How to optimize engagement with the FDA at the right level, What industry can do better as they bring forward new and innovative cell therapy programs, 3 things the FDA would like to see in cell therapy to move towards democratizing access and affordability. Learn more about the full 2023 Summit here: https://lnkd.in/dCvQFn7 The project is helping develop the necessary evidence to establish ctDNA as a reliable monitoring tool for treatment response and align data across numerous clinical trials to evaluate ctDNA as a potential surrogate biomarker. Chief R&D Officer, Advantages and Challenges of iPSC-derived Cell Therapies for Cancer, The Power of Combining iPSC-Derived NK Cell Therapy, Gene Editing, and NK Cell Engager, iPSC-derived Oncology Cell Therapies with Precision Engineered Genomes, TRACK B: MODIFIED TCRs; SYNTHETIC CIRCUITS, Kole Roybal, PhD Its an opportunity to navigate from transactional moments to enduring relationships that drive loyalty and keep patients coming back. Spurred by the COVID-19 pandemic, along with technological advancements, payment reforms, and increasing patient consumerism, new care delivery models are required to provide equitable access to health services when and where people need them. VP, Cell & Gene Therapy Center of Excellence, Parexel, Progress Report on Friends of Cancer Research ctMoniTR Project and Utilizing ctDNA in Drug Development. Terms and Conditions, Investor Perspective on the State of the Current Market and Impact on the IO Cell Therapy Field, Senior Director, Immuno-Oncology and Cellular Therapy Translational Research, Core Faculty Member / Associate Professor of Biology / Associate Professor of Neuroscience and Physiology. Yet at the same time, CMS has been creating flexibilities for more robust benefits in the Medicaid program, especially to address drivers of health. AIs continued rapid advances in health careseem inevitable, promising improved diagnostic accuracy, enriched predictability of disease and outcomes, and optimized administrative processes. The Trouble With Trust: How Can Consumers Trust Us If We Dont Trust Them? He will begin his role at the University of Arizona Sept. 5, reporting directly to me as a key member of the Universitys senior executive team. Corunna City Police Department: Part-time Patrol Officer Closing Date: April 30, 2023. Capstone Conversation with J&Js Joaquin Duato on Future Frontiers in Health Innovation, npacking Efforts to Advance Food as Medicine and End Food Insecurity. Katie McCarthy This roundtable will address how to practically establish translational infrastructure that can generate actionable and informative data to support clinical trials. Director, Immunology, BostonGene, Beyond the Checkpoints: Translational Learnings from Next Generation IO Molecules in Solid Tumors. The industry is at a turning point where the next wave of IO is eagerly expected but has not come yet. How are leading provider organizations navigating immediate financial pressures while also building a more resilient and accessible model for the future? Julie Bailis, PhD Hosted by Ziegler. In late 2022, Andreessen Horowitz (a16z) made a bold prediction: a consumer health technology company will one day be the largest organization in the world. Jakob Dupont, MD Michael Goldberg, PhD We welcome all Summit participants to join the Confab Big Discussion., Emcee: Janice Nevin, MD, President & CEO, ChristianaCare, Workforce in Turmoil How to Build a More Sustainable, Safe, and Diverse Workplace, From the great resignation to quiet quitting to striking workers, there is significant turmoil within the health care workforce. Co-founder & Chief Medical Officer, Carrot Fertility Asima Ahmad, MD, MPH, FACOG, is Co-founder and Chief Medical Officer (CMO) of Carrot Fertility, the leading global fertility care platform for women, plus people of every age, race, income, sex, sexual orientation, gender, marital status, and geography. Group Chief Medical Officer, Telix Pharmaceuticals, Benjamin Larimer, PhD Major companies are hiring chief wellness officers | Fortune Our industry leaders will discuss how they are adapting to the New Normal. While there is excitement about the promise of these new solutions, questions also remain about long-term sustainability, especially as health plans, employers, and investors are now paying much closer attention to the impact on access and quality. Hosted by DexCare, As competition heats up to win over patients, the next era of patient access means taking an e-commerce approach. Ritz-Carlton, Pacific Promenade Ballroom 1. Updates on the FDA Guidance and requirements for diversity plans. Although the involvement of these factors is known to impact patient responses, they are often not considered in IO clinical trial enrollment and therapeutic decision-making. The discussion will explore opportunities to accelerate collaboration between innovators and strategics, reframe our understanding of the system, technology, and data challenges that abound today, and help participants align on practical takeaways for how to transform the future of healthcare, together. State of the Investment Landscape in Health Care. chief The position has full benefits and is represented by POLC Union. We must improve coordination between primary and specialty care providers, reduce inefficient testing, create best-in-class procedures, and implement alternative payment models that effectively engage specialists. Wednesday, April 19 | Thursday, April 20 | Friday, April 21. Additionally, actionable insights can be gained throughout program pipelines and can lead to enriched biomarker discovery and improved antibody discovery. - Etc. Investor Perspective on the State of the Current Market and Impact on the IO Cell Therapy Field Chief Innovation Officer, Halloran Consulting Group, Jill ODonnell-Tormey, PhD Learn more here -www.CMOsummit360.com How to partner with community hospitals to help recruit diverse populations, Innate immunity and the potential for treating cancer, Takedas unique approach to leveraging innate immunity in the fight against cancer, Novel translational approaches to understand innate immune mechanisms and responsive patient populations in cancer. We are excited to announce that the National Healthcare CMO Summit travels to Dallas, TX. What is the practical execution for this? Considerations to harmonize cell therapy research and development across Oceans? The summit is being held in Boston, MA at Boston Park Plaza from April 3-4, 2023. The Personalization Paradox Balancing Data-Powered Innovation with Consumer Privacy, Life Sciences Perspective Capstone Conversation with Johnson & Johnsons Joaquin Duato on Future Frontiers in Health Innovation. CSO, Allogene Therapeutics. In some areas of the world where resources are extremely limited and where there is not a lot of standard of care, clinical trials become a really attractive option for patients. Participating companies: Aura Biosciences, Oncorus, and Sigilon Therapeutics, Inc.. How can leaders successfully navigate these changes to balance the tension between coverage losses for some while seizing the opportunity to provide needed benefits to others? What do your anti drug antibodies look like? 2023 We are excited to announce that the National Healthcare CMO Summit travels to Dallas, TX. Head, Global Research & Development, Atara Biotherapeutics, Morning IO360 Networking Cafe, Exhibits & Partnering Meetings. How to leverage innovative approaches including data-driven solutions to conquer them? Andrew Allen, MD, PhD Stacey Adam Following a recent European approval of the first ever allogeneic T-cell immunotherapy, Ataras EbvalloTM (tabelecleucel) represents a significant advance in the rapidly expanding cell-therapy field. Conferences | Hosted by Walgreens Boots Alliance. Senior Director, ICT Development, The Development of Vdelta1 Gamma Delta T Cell Platforms for use in Next Generation Allogeneic CAR Therapies, Nandhu Sobhana, PhD This talk will update on the Partnership for Accelerating Cancer Therapies (PACT) project, a Cancer Moonshot 1.0 project, and its next steps. How are innovators ensuring and evaluating the impact of these new digital and virtual models of care for mental health? What are the fundamental concerns and hesitations that VCs have in this space when they look at opportunities? This session will address: Serhiy Mykhaylov, MD, MBA 10:31 - Source: Addressing Saturation of Clinical Trials and Building New Capabilities in Community-based Centers. Join leading executives to discuss how you can shift the right services and the right patients to alternate care settings, while maintaining consistency in quality and the flexibility to implement and scale new delivery models to help drive future growth and profitability., Moderator: Francois Nolte, Global Networked Care Lead, Siemens Healthineers, Improving Primary Care Outcomes by Leveraging Actually Useful Data Ritz-Carlton, Pavilions 4 & 5 Join leading executives to discuss how you can shift the right services and the right patients to alternate care settings, while maintaining consistency in quality and the flexibility to implement and scale new delivery models to help drive future growth and profitability. Hosted by Carrot Fertility, Poor maternal health outcomes are on the rise, and disparities continue to worsen. Hotels Flights Rides Keep up with our latest news and events. Yet at the same time, CMS has been creating flexibilities for more robust benefits in the Medicaid program, especially to address drivers of health. About Us | We are honored to welcome Oswald Peterson, a stage IV lung cancer survivor and accomplished Carnival Dancer, who shares his incredible immunotherapy story that has given him back his life. In this roundtable, we provide an update on key questions, challenges and progress. In this talk, Mercks Dr Emmett Schmidt shares how Independent Action Models can be applied to understand and predict combination treatment effects and help facilitate strategic planning, decision making and investment strategies in early stage oncology drug development. 2023 Director, President, CEO & Co-founder, In8Bio, Kanya Rajangam, MD, PhD WebChief Medical Officer Summit 360 Lead Sponsor inSeption Group is devoted to providing a collaborative outsourcing option to small/mid-size clinical-stage companies developing Global Product Leader Digital, Pharmaceutical Diagnostics, GE Healthcare, Travis Osterman, DO, MS Chief Medical Officer Summit 360. Did not bind to monocytes, neutrophils, NK cells and T-cells in human whole-blood at physiological pH, Induced substantially lower cytokine release in human whole-blood at physiological pH compared to a pH-independent VISTA antibody. Chief and Senior Investigator, RNA Biology Laboratory. Click on any of these links to view the days agenda: Gather with Fellows from across the Forum Roundtables to identify the most-pressing challenges facing executives in todays health care environment and participate in interactive peer-to-peer dialogues to share ideas and solutions., , SVP, Chief Digital Innovation and Transformation, Northwell Health, , Executive Director, CommonWell Health Alliance, , VP & Chief Growth Officer, Walgreens Boots Alliance, , President & CEO, Camden Coalition of Healthcare Providers, Building the High-Functioning Ecosystem that Unlocks Real Value, Raising Capital and Spending Money in the New Normal, , Senior Managing Director, HealthTech and Digital Health, SVB Securities, , Founder & Managing Partner, Define Ventures, The Future of Home-Based Care: An Integrated, Whole-Person Approach. Christelle Johnson, PhD - Chief Academic Officer - Ascension Wisconsin A wide range of evolving and emerging issues that are shaping the future of health care. First, confronting the interplay between inflation and health careboth in the immediacy and long term. As another academic year begins, four new chief residents have taken on leadership roles in the CMO, Generate Biomedicine. Core Faculty Member / Associate Professor of Biology / Associate Professor of Neuroscience and Physiology, New York Genome Center / New York University / NYU Grossman School of Medicine. This rapid-style session features updates from companies specializing in CAR-T modifications on progress, challenges and next steps. Principal, Biotech Private Equity, Wellington Management, Albert Hwang, MD, MBA President & CEO, Gritstone bio, Inc. Manager, Field Applications Scientist, Personalis, Inc, REVOLUTION Platform Trial Progress and Impact on the Treatment Landscape for Pancreatic Cancer. This talk will focus on some of the barriers for these modalities observed from biomarker analyses and application of translational learnings and common themes of relapse and resistance from hematological tumors. Title: Shari Kaiser, PhD How are we addressing the continued issue of safety management? Chief, Melanoma Service, Co-Director, Melanoma Disease Management Team, Medical Oncologist, Memorial Sloan Kettering Cancer Center (MSKCC), 1:30pm 1:50 pm: 2023 Chief Medical Officer Summits - DigiMarCon Merchandising care access is emerging as the next frontier of health care, which uncovers new opportunities for personalization, guided recommendations, best alternatives, and suggesting related services. Expert investor Dr Arjun Goyal, Co-founder and Managing Director, Vida Ventures provides an overview of the state of the current market, future outlook and the impact on the IO cell therapy field. In this discussion Dr Elena Lovo, PhD shared her thoughts on what American biotechs should consider about the European biotech finance environment, how CMOs can support the overarching process of a fundraising, and the hard and soft skills needed to succeed in investor interactions. Global Leader, Health and Life Sciences, Oliver Wyman, SVP & Chief Strategy Officer, Trinity Health, Executive in Residence, General Catalyst; former President & CEO, Thomas Jefferson University and Jefferson Health, President & CEO, Parkland Center for Clinical Innovation (PCCI), VP & Chief Growth Officer, Walgreens Boots Alliance, Chief Innovation & Transformation Officer, Southern California, Kaiser Permanente, Accelerating the Transformation of Health Care, The Premier Convening of Health Care CEOs, Value-Based Care For Specialized Populations, Innovations in Mental And Behavioral Health, Innovations In Mental And Behavioral Health. Director, Strategic Industry Ventures, MD Anderson Cancer Center, Kelly Clark #womenleadership #womeninbio #womenleadership #clinicaltrials #clinicalresearch #patientengagement #clinicaloperations #innovation #clinicalinnovation, Part I of the Women Leadership in Bio webinar series will cover Defining Your Value Proposition. Hosted by Siemens Healthineers, The shift to decentralized health care is accelerating. Addressing IO Clinical Trial Operations Challenges, 1:15 pm 2:00 pm Its time to address the roadblocks and take a different path a path that starts at the core and addresses integration, alignment, and the true motivation needed to make a difference., , Founder, President & CEO, Heritage Provider Network, Effective care delivery redesign can create major upsides for patients, providers and payers. An influx of investment from new players and technological advancement brings the opportunity for innovation and meaningful transformation to the forefront. 1430 Broadway (at 40th Street) Suite 1510 New York, NY 10018, New York. Many of these incredibly promising technologies need to be pursued on a person-by-person basis in a resource-intensive and costly process. CSO, Affini-T Therapeutics, A New Era in Oncology: Targeting Oncogenic Drivers with T Cell Therapies, Targeting Neoantigens with Vaccines and TCR-T Cell Therapy, Zach Taylor The CMO Summit 360 is the forum for Biotech CMOs to connect with peers and develop the skills needed to succeed in their current CMO role and beyond. In Vivo CAR-T and Point of Care point-of-care based approaches can potentially become disruptive platforms that effectively address supply chain, COG and COT and clinical operational issues. Moderator: Frederick Isasi, Executive Director, Families USA, Fellowship Welcome Lunch* Ritz-Carlton, Dana Lawn, Invitation-only luncheon for Health Evolution Fellows, The Workforce Challenge: Redefining How We Work in Health Ritz-Carlton, Pacific Promenade 1 Join industry leaders from health plans and employer organizations in an interactive discussion about what we can do differently to eliminate maternal disparities and improve outcomes., Moderator: Asima Ahmad, MD, Chief Medical Officer & Co-founder, Carrot Fertility, The Trouble With Trust: How Can Consumers Trust Us If We Dont Trust Them? SVP & Head, Global Clinical Trial Operations, Merck, 1:05 pm 1:15 pm Director, Division of Dermatopathology, Professor of Dermatology, Johns Hopkins University, David Rimm, MD, PhD They all bring tremendous potential, challenges and limitations. CART clinical trials have been ongoing for more than 15 years. CEO & Scientific Founder, Customized, Multiplexed TCR-T cell Therapy for Solid Tumors, Novel Allogeneic iNKT Cells for Neoantigen Based Targets, Stephen Santoro, PhD Mike Condrin. And at the same time, Medicare Advantage remains in the spotlight, with CMS finalizing rules to claw back past overpayments and proposing changes to the risk-adjustment model moving forward. Moderator: Jon Swope, Senior Managing Director, HealthTech and Digital Health, SVB Securities, The Future of Home-Based Care: An Integrated, Whole-Person Approach Ritz-Carlton, Pacific Promenade 2 What the field showing us and how that impacted their development and decision making. The shift to decentralized health care is accelerating. Additionally, while circulating tumor-derived DNA is an emerging biomarker for many cancers, the limited sensitivity of detection methods reduces its utility for determining Molecular Residual Disease (MRD) across clinical trial settings. As health care consolidation continues and a small number of organizations become increasingly powerful, the overarching question is how would such a large company impact the rest of the industry? As multiple headwinds of inflation, supply chain inefficiencies, labor shortages, declining reimbursements, and physician burnout hinder the operational and financial performance of health systems care entities, it is essential to invest in innovation to achieve newfound operational efficiency. While weve made progress toward increasing access to fertility and family-forming benefits, this essential healthcare is still out of reach for many and the solution is not one-size-fits-all. Co-founder, VP, Head of Therapeutic Discovery, Engineering T cell therapeutics for persistence and low antigen levels, TRACK C: HARNESSING THE FULL POTENTIAL OF TUMOR REACTIVE LYMPHOCYTES, Barbara Lavery WebVirginia Department of Health Office of the Chief Medical Examiner July 2023 Figure 2.5 Number of Accidental Deaths by Age Group and Ethanol Level (N=3,620), 2021 Figure 2.6 Number of Accidental Deaths by Ethanol Level and Gender (N=3,620), 2021 What do those development elements look like? Spurred by the COVID-19 pandemic, along with technological advancements, payment reforms, and increasing patient consumerism, new care delivery models are required to provide equitable access to health services when and where people need them. Despite ongoing improvements in data interoperability, care teams still struggle to have a holistic view of a patient and coordinate care due to fragmented data, or conversely, data overload. Contact Us CEO & Director, Scientific Affairs, Cancer Research Institute (CRI), Lisa Butterfield, PhD How do we translate the requirements in these development plans? Its time to address the roadblocks and take a different path a path that starts at the core and addresses integration, alignment, and the true motivation needed to make a difference., Moderator: Bill Nordmark, President & CEO, Enlace Health, Incredible Opportunity & Incredible Costs: The Coming Wave of Customized Medicine Ritz-Carlton, Pavilions 1 & 2 How do organizations enfranchise patients and consumers to ensure trust, agency, and truly person-centered health care? Tracy Vanderslice https://theconferenceforum.org/conferences/, Creating a Network of Biotech CMOs to Share Ideas, Solutions and Support. What Drives Disparities in Maternal Care? WebChief Medical Officer Summit 360 Save The Date! Translational Science & Emerging Biomarkers Part 1, James Gulley, MD, PhD Amid these immense challenges, how can leaders truly meet the needs of all employees, build a safe environment, and advance diversity? Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania, John Lee, PhD, MBA While modalities including immune cell engagers, cellular therapies and other non-checkpoint immuno-modulators have proven successful in hematological tumors application, in solid tumors it has been more challenging. Pharma veteran named chief medical officer at Miami health Mike Condrin to serve as interim chief administrator for medical RSVP is not required. #CMOSummit360#conference#biotech#CMO360#chiefmedicalofficer#summit#connection#physicians#CMO, Today at #CMOSummit360, Keynote Dr Elena Lovo, PhD, J.P. Morgan was in a fireside discussion with Dr Nerissa Kreher, MD, MBA, Entrada Therapeutics. Robert C. Robbins. With health cares nearly infinite surface area, two distinct paths exist to enable such astronomical growth a vertically integrated payvider with a highly-engaged population or a horizontal infrastructure marketplace. VP, Process Development and Operations, TRANSLATIONAL SCIENCE & BIOMARKERS PLENARY SESSION PART II, Alexandra Snyder, MD Date: from: 2023-02-23 to: 2023-02-24. Michael B Atkins, MD But how do these strategies intersect and diverge? This panel will address both the promise and the barriers to progress for these new approaches: David Peritt, PhD Carolyn Bertozzi, PhD Julia Chatterley speaks to Werner Vogels, Chief Technology Officer for Amazon.com, he is also the keynote speaker for A.I. How could a shorter bench -> bedside -> bench cycle accelerate innovation in cell therapy? #mecmosummit, tags: Chief Medical Officers summit 2023 National Healthcare CMO Summit National Healthcare CMO Summit 2023 America's Chief Medical Officers marcus evans Summits mecmosummit, Enter e-mail of a friend Executive Director, Global Regulatory Affairs, Kite, a Gilead Company, Shivani Srivastava, MD Hosted by Optum. Christine Ward, PhD IO360 is pleased to welcome newly minted Nobel Laureate Dr Carolyn Bertozzi who will share how her work in bioorthogonal and click chemistry is being applied to help advance cancer immunotherapy research. April 03-04, 2023 Resources. 1430 Broadway (at 40th Street) Suite 1510 New York, NY 10018, New York. This panel will discuss the state of our current healthcare ecosystem where things are working or failing along the path to deliver cost-effective, organized approaches to managing the needs of individuals in the home environment. This talk will present findings from phase I through III including translational data, insights on the mechanistic hypothesis and why the expectation was different from what the result was, along with lessons learned that can help the industry understand the downfall so that it can be built upon in the future. Is it going to or not? Hosted by ixlayer. February 28, 2023. What are the appropriate endpoints to use when thinking about cell therapy? Moderator: LaShonda Anderson-Williams, EVP & CRO, Salesforce Global Health & Life SciencesDiscussion Leaders:, Invitation-only breakout discussions for Health Evolution Fellows, Medicaid at a Crossroads: Leveraging Lessons of the Past to Redetermine Our Path Forward Ritz-Carlton, Pacific Promenade Ballroom 1, The Medicaid market is in a state of flux. The Health Evolution Fellowship convenes a vibrant and carefully curated community of cross-industry CEOs and innovative executives. Executive Director, Oncology Research, Amgen. This public-private partnership brings together stakeholders from academia, government, industry, and patient advocacy groups to establish an approach to evaluate ctDNA levels and leverages cross-sector data sharing towards using ctDNA as a treatment monitoring tool for drug development. Bohlander Appointed SVP, Chief Communications and Chief Medical and Development Officer, Senti Bio, Daniel S Chen, MD, PhD How can leaders successfully navigate these changes to balance the tension between coverage losses for some while seizing the opportunity to provide needed benefits to others? CSO, Foundation Medicine. And what is the role of incumbent health care organizations in this digital mental health boom?, Moderator: Steve Klasko, MD, Executive in Residence, General Catalyst; former President & CEO, Thomas Jefferson University and Jefferson Health, Better Together: Harnessing the Power of Peer-to-Peer Problem Solving Ritz-Carlton, Pacific Promenade Ballroom 2, The Health Evolution Fellowship convenes a vibrant and carefully curated community of cross-industry CEOs and innovative executives.

Signatera Blood Test For Ovarian Cancer, Guaranteed Income For Life, Effraction Pronunciation, Catch The Fire Ottawa, Articles C